Ritlecitinib is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents12 years and older.
Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.
from FDA,2023.06